Atea Pharmaceuticals Current Cash

Atea Pharmaceuticals (AVIR) currently reports a current cash of $77M as of June 2026. That compares with $88M in the prior-year period — down 12.7% year over year. Use the charts on this page to explore Atea Pharmaceuticals's current cash history and peer comparisons.

Atea Pharmaceuticals's current cash decreased from $88M to $77M — a 12.7% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Atea Pharmaceuticals reported $77M in current cash as of June 2026. That compares with $88M in the prior-year period — down 12.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $77M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Atea Pharmaceuticals, and consider following AVIR for alerts when major investors trade the stock.

Atea Pharmaceuticals is classified in the Healthcare sector. On current cash, it currently shows $77M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AVIR with unrelated industries.